However, the Wellness Path isnt available as a standalone option at this time, and its unclear when it will return
As of the date of this article, there are no published clinical trials, peer-reviewed studies, or regulatory-approved protocols examining the combined use of retatrutide and tesamorelin
12 While these contain the same active ingredients (Semaglutide and Tirzepatide), they are officially approved and labelled for Type 2 Diabetes
Ipamorelin: Acts as a selective Ghrelin receptor agonist
Vandewalle, J., Luypaert, A., De Bosscher, K., & Libert, C
It suggests that initiating treatment with GLP-1 agonists may be more effective than metformin in reducing dementia risk among individuals with type 2 diabetes